The Intercept @theintercept
In March, @fastlerner and @lhfang exposed how a coronavirus treatment developed by Gilead Sciences was granted “rare disease” status, potentially limiting its affordability. Days later, Gilead asked the FDA to rescind the drug's special status. https://t.co/tGBVVghzLA — PolitiTweet.org